PP
OSIR

PDT Partners’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

PDT Partners’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,638
Closed -$96K – 580
2016
Q4 		$96K Buy
19,638
+2,438
+14% +$12.5K 0.01% 490
2016
Q3 		$85K Sell
17,200
-2,300
-12% -$11.8K 0.01% 466
2016
Q2 		$99K Buy
+19,500
New +$105K 0.01% 430
2015
Q3 		– Sell
-16,391
Closed -$319K – 1814
2015
Q2 		$319K Buy
16,391
+4,561
+39% +$80.7K 0.01% 1116
2015
Q1 		$208K Buy
+11,830
New +$199K 0.01% 1262

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

PDT Partners's OSIR Position: Q1 2017 in Review

PDT Partners sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 19,638 shares — an estimated $96K sold.

PDT Partners first reported a position in OSIR in Q1 2015 and held it in 5 quarters. The position peaked at $319K in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • PDT Partners reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • PDT Partners sold 19,638 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $96K.
  • PDT Partners first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
  • PDT Partners's Osiris Therapeutics, Inc. Common Stock position peaked at $319K in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on PDT Partners's 13F filing for Q1 2017, filed 15 May 2017.